Brilinta DaYu Study

NCT01870921 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2004

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Ticagrelor

Sponsor

AstraZeneca